MedTrace Logo

Vascular Endothelium Changes After Bariatric Surgery (Endothelial Progenitor Cells)

NCT01213940 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-05-09

Study results available
· View outcomes & findings →

Summary

Improvement in cardiovascular mortality is related to changes in pathologic autoantibodies and in the number of circulating functional replicative competent endothelial progenitor cells (EPC's) after bariatric surgery.

Conditions

Interventions

BEHAVIORAL

pre-bariatric weight loss program

standard 6 month physician directed pre-bariatric weight loss program

PROCEDURE

bariatric surgery

bariatric surgery for weight loss

Sponsors & Collaborators

  • American Society for Metabolic and Bariatric Surgery

    collaborator OTHER

  • University of South Alabama

    lead OTHER

Principal Investigators

  • William O Richards, MD · University of South Alabama, Department of Surgery

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01213940 on ClinicalTrials.gov